Federal RuleAug 21
62
DOL Rewrites Disability Rules for 'Merit-Based Opportunity' Push
RuleLabor DepartmentFederal Contract Compliance Programs OfficeSignificant Wallet
116-hr-2374116th Congress
Stop STALLING Act
Sponsored By: Representative Jeffries, Hakeem S. [D-NY-8]
Unknown
Summary
Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act or the Stop STALLING Act This bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug. The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a petition to the FDA. A party found liable in such a lawsuit shall be subject to civil penalties, such as a fine of up to $50,000 for each day that the FDA spent reviewing the baseless petition.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
Jeffries, Hakeem S. [D-NY-8]
NY • D
Cosponsors
Sen. Welch, Peter [D-VT]
VT • D
Sponsored 4/29/2019
Rep. Sensenbrenner, F. James, Jr. [R-WI-5]
WI • R
Sponsored 4/29/2019
Rep. Nadler, Jerrold [D-NY-12]
NY • D
Sponsored 4/29/2019
Rep. Collins, Doug [R-GA-9]
GA • R
Sponsored 4/29/2019
Rep. Cicilline, David N. [D-RI-1]
RI • D
Sponsored 4/29/2019
Rep. Cohen, Steve [D-TN-9]
TN • D
Sponsored 4/30/2019
Rep. Posey, Bill [R-FL-8]
FL • R
Sponsored 12/9/2019
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov